Skip to content

Pharmacokinetics of Thiamine in Breastfeeding Mothers and Infants

Pharmacokinetics of Thiamine in Breastfeeding Mothers and Infants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01864057
Enrollment
24
Registered
2013-05-29
Start date
2012-01-31
Completion date
2012-09-30
Last updated
2013-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beriberi

Keywords

thiamine deficiency

Brief summary

Thiamine deficiency causes beriberi and is common in parts of rural Cambodia, where it appears to be a leading cause of infant death. The change in maternal and infant thiamine level after administration of thiamine to either Cambodian mothers or their infants is unknown. Normal human breast milk thiamine levels in thiamine-replete mothers are poorly characterized. The aim of this study is to determine if thiamine administered to nursing Cambodian mothers normalizes maternal and infant thiamine levels. Levels will also be obtained in nursing Caucasian mothers residing in the United States.

Detailed description

In this pharmacokinetic study, thiamine hydrochloride 100 mg will be administered to nursing Cambodian mothers and thiamine levels will be measured in their blood and breast milk before and after supplementation. Their infant's blood thiamine levels will also be measured. A control arm of American breast feeding mothers taking prenatal vitamins will also be enrolled, to allow comparison of maternal blood and breast milk levels between Cambodian and American mothers. Ethics committee approval was obtained in Cambodia (National Ethics Committee for Health Research #208, 2011) and in the United States (Mayo Clinic Rochester IRB #12-004047)for the Cambodian and American portions of the protocol, respectively.

Interventions

Sponsors

Eastern Mennonite Missions
CollaboratorUNKNOWN
ARUP Laboratories
CollaboratorOTHER
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Mother is at least 18 years of age * Infant is between 1 and 12 months of age * Cambodian infant is exclusively breast fed * Cambodian mother has not taken vitamin supplements within the past month * American mother has been taking prenatal vitamins throughout pregnancy and postpartum while breastfeeding * Mother and infant do not have an acute illness at the time of enrollment * Mother and infant are able to comply with study visits

Exclusion criteria

* Mother is not able to provide informed consent * Cambodian infant has received thiamine injections within the past 2 months

Design outcomes

Primary

MeasureTime frameDescription
blood thiamine concentration5 daysblood thiamine and thiamine diphosphate concentrations after 5 days of maternal oral thiamine supplementation

Secondary

MeasureTime frameDescription
breast milk thiamine concentration5 daysbreast milk thiamine concentration after 5 days of maternal thiamine supplementation

Other

MeasureTime frameDescription
infant thiamine concentration5 daysinfant blood thiamine and thiamine diphosphate concentrations after 5 days of maternal supplementation

Countries

Cambodia, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026